Literature DB >> 25073592

NICE gives go ahead to intrabeam radiotherapy for breast cancer.

Helen Mooney1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25073592     DOI： 10.1136/bmj.g4863

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Health economics of targeted intraoperative radiotherapy (TARGIT-IORT) for early breast cancer: a cost-effectiveness analysis in the United Kingdom.

Authors:  Anil Vaidya; Param Vaidya; Brigitte Both; Chris Brew-Graves; Max Bulsara; Jayant S Vaidya
Journal:  BMJ Open       Date:  2017-08-17       Impact factor: 2.692

2.  Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer-better for patients, better for healthcare systems.

Authors:  Jayant Sharad Vaidya; Uma Jayant Vaidya; Michael Baum; Max Kishor Bulsara; David Joseph; Jeffrey S Tobias
Journal:  Front Oncol       Date:  2022-08-11       Impact factor: 5.738
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.